KANSAS — Patients For Affordable Drugs Now announced it will extend its campaign thanking Rep. Sharice Davids (KS-03) for supporting H.R. 3, a bill that would lower drug prices by allowing Medicare to negotiate on behalf of Kansans. The new phase of the campaign will start July 2 and will include digital video ads as well as grassroots advocacy, in which patients will contact Rep. Davids directly to thank her for standing with patients against Big Pharma. 

“H.R. 3 will ensure Kansans have access to affordable medicine while protecting innovation for the future,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “On behalf of patients, we thank Rep. Davids for standing up to Big Pharma and fighting to pass this important legislation to lower the price of prescription drugs.”

The expanded push will include a new video ad highlighting Steven Hadfield, a patient from Charlotte, North Carolina, who lives with a rare blood cancer and is prescribed a medication priced at $132,000 a year. The ad thanks Rep. Davids for supporting H.R. 3 and urges constituents to ask her to keep fighting for lower drug prices. 

“I’ve been fighting it for seven years,” Steven says in the ad playing on digital platforms. “$132,000. That’s the annual price for my cancer medication. I live in fear over my high drug prices. You wonder how everybody else survives.”

You can watch the ad here

P4ADNow’s campaign to support H.R. 3 was first launched on May 20 on the heels of Big Pharma’s [http://]attack ads loaded with lies, pressuring members of Congress not to support H.R. 3. 

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, was reintroducedin the House of Representatives in April. The chamber passed the bill in the 116th Congress. It will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.

The Kansas campaign is part of Patients For Affordable Drugs Now’s national campaign across 44 House districts.